Peter Attia, MD is wrong about Prostate Cancer and PSA

Peter Attia, MD is wrong about Prostate Cancer and PSA

From Intellectual Medicine by Dr. Stephen Petteruti

May 5, 2026 · 16 min

About this episode

Dr. Stephen Petteruti critiques common guidance on PSA testing and prostate cancer detection, emphasizing the need for informed health decisions.

Clear thinking leads to stronger health decisions and better long-term outcomes. In this episode, Dr. Stephen Petteruti takes a closer look at common guidance around PSA testing and early prostate cancer detection, including viewpoints from Peter Attia, MD. He explains how impressive-sounding statistics can mislead, showing that a 44% relative risk reduction translates to only a 0.34% actual benefit. He reframes PSA as a monitoring tool. The typical pathway often leads to harm without proven life extension. Evidence from long-term studies shows no meaningful difference in prostate cancer mortality between aggressive treatment and observation. Rethink the numbers and make choices that support both your health and future. Don’t miss the full episode of Peter Attia, MD is wrong about Prostate Cancer and PSA. Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms. Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His…

People in this episode

Host: Dr. Stephen Petteruti

Topics covered

  • prostate cancer
  • PSA testing
  • health decisions
  • long-term outcomes
  • evidence-based medicine

Keywords

  • prostate cancer
  • PSA
  • health decisions
  • statistics
  • treatment options

Mentioned in this episode

Organizations: Intellectual Medicine

More episodes of Intellectual Medicine

Explore listener stats, chart rankings, contacts and more on the Intellectual Medicine podcast page.